Moderna's Latest Study Shows Promising Results for New Covid Vaccine

Tuesday, 26 March 2024, 15:25

Moderna reports that its new Covid vaccine demonstrated a more robust immune response compared to the current shot. The new vaccine also has the potential for an extended shelf life and forms part of a combination vaccine targeting both Covid and the flu. These findings indicate a positive step towards enhancing vaccine efficacy and addressing potential future viral challenges.
https://store.livarava.com/2459f111-eb86-11ee-aec1-63fd8ea994ba.jpg
Moderna's Latest Study Shows Promising Results for New Covid Vaccine

Moderna Announces Stronger Immune Response for New Covid Vaccine

Moderna reported that its new Covid vaccine showed a stronger immune response compared to the current shot.

Potential for Longer Shelf Life

The new vaccine offers the potential for an extended shelf life.

This new vaccine is part of a combination vaccine targeting both Covid and the flu.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe